S1PR3 and neoplasm: In the tumor, activation of the S1PR3-ERK1/2 MAPK pathway on MDSC by FTY720 results in increased expression of granulocyte-macrophage colony-stimulating factor (GM-CSF), resulting in MDSC accumulation in the tumor niche and autocrine stimulation of immunosuppressive functions of these cells [408–410].